Evidence map›Paper›PMID 35101215›Full record

ArticleMethods in enzymology2022

Identification of selenoprotein O substrates using a biotinylated ATP analog.

Meghomukta Mukherjee, Anju Sreelatha

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Methods in enzymology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Selenoproteins and the senescence-associated epitranscriptome.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Meghomukta MukherjeeDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Anju SreelathaDepartment of Physiology, University of Texas Southwestern Medical Center, Dallas, TX, United States; Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: anju.sreelatha@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

Novel mechanisms of redox signaling in acute kidney injuryK01DK123194 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI SREELATHA, ANJU · 2020 to 2023
$598k
NIDDK NIH HHS K01 DK123194
6 · The paper itself

Abstract

Selenoprotein O is one of 25 human selenoproteins that incorporate the 21st amino acid selenocysteine. Recent studies have revealed a previously undocumented mechanism of redox regulation by which SelO protects cells from oxidative damage. SelO catalyzes the covalent addition of AMP from ATP to the hydroxyl side chain of protein substrates in a post translational modification known as AMPylation. Although AMPylation was discovered over 50 years ago, methods to detect and enrich substrates are limited. Here, we describe protocols to clone, purify, and identify the substrates of bacterial SelO using a biotinylated ATP analog. Identification of SelO substrates and the functional consequences of AMPylation will illuminate the significance of this evolutionarily conserved selenoprotein.

Indexed as

Protein Processing, Post-TranslationalSelenoproteinsAdenosine TriphosphateHumansOxidation-ReductionOxidative StressAdenosine TriphosphateSelenoproteinsAdenylylationAMPylationMitochondriaOxidative stressPseudokinaseSelenoOydiU

Identifiers

PMID35101215
OpenAlexW4210260677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.